​

Funding Round

Series B - Zenas BioPharma

Series B - Zenas BioPharma

Investment Firm

Overview

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Announced Date

Nov 07, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Enavate Sciences

Enavate Sciences

Enavate Sciences is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

10

Investor Name
Participant InvestorLongitude Capital
Participant InvestorXencor
Participant InvestorPivotal bioVenture Partners
Participant InvestorWellington Management
Participant InvestorVivo Capital

Round Details and Background

Zenas BioPharma raised $118000000 on 2022-11-07 in Series B

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 07, 2022
Series B - Zenas BioPharma
13-118.0M
Mar 23, 2021
Series A - Zenas BioPharma
5-undefined
May 07, 2024
Series C - Zenas BioPharma
15-200.0M

Recent Activity

There is no recent news or activity for this profile.